Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy

► Identifying inflammatory markers (here, sTNF-R1 and IL-6) of chemoradiation-induced fatigue is a step toward confirming these biomarkers as a target for mechanism-based symptom management.